These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15116254)

  • 1. Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin.
    Hoke M; Kyrle PA; Philipp K; Pabinger I; Kaider A; Schönauer V; Quehenberger P; Eichinger S
    Thromb Haemost; 2004 May; 91(5):935-40. PubMed ID: 15116254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
    Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
    Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombogenesis in Thrombophilic Pregnancy: Evaluation of Low-Molecular-Weight Heparin Prophylaxis.
    Simeone R; Giacomello R; Bruno G; Parco S; Maximova N; Martinelli M; Zito G; Luppi S; Cervi G; Ricci G
    Acta Haematol; 2017; 137(4):201-206. PubMed ID: 28478442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombophilia and HELLP syndrome in pregnancy - case report and overview of the literature].
    Findeklee S; Costa SD; Tchaikovski SN
    Z Geburtshilfe Neonatol; 2015 Feb; 219(1):45-51. PubMed ID: 25734477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T; Raddatz Mueller P; Fehr J
    Haemostasis; 2001; 31(2):90-8. PubMed ID: 11684864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia.
    Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z
    Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
    Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
    Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of venous thromboembolism in pregnancy.
    James AH
    Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
    Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
    Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy and prevention of deep venous thrombosis and pulmonary embolism in gynecology and obstetrics].
    Vucić N; Cala K; Rancić I; Pticar R
    Acta Med Croatica; 2003; 57(2):123-30. PubMed ID: 12879692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
    Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I
    Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.